Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Hani Sabbour"'
Autor:
Aftab Ahmad, Hani Sabbour
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-22 (2024)
Abstract Background Randomized controlled trials and real-world studies suggest that combination therapy with sodium–glucose transport protein 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is associated with improv
Externí odkaz:
https://doaj.org/article/ee782da5459d40f99ee6440e6ca13b5b
Autor:
Yosef Manla, Laila AbdelWareth, Ronney Shantouf, Yazan Aljabery, Terrence Lee St John, Hani Sabbour, Bartlomiej Piechowski-Jozwiak, Wael Almahmeed
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundLipoprotein(a) [Lp(a)] is a genetically determined risk factor for atherosclerotic cardiovascular disease (CVD). Limited data are available on Lp(a) testing from the Middle-East region. Therefore, we aim to evaluate the utilization and yiel
Externí odkaz:
https://doaj.org/article/67ed7af59f4540d6a6ff02981adf925b
Autor:
Aftab Ahmad, Hani Sabbour
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/42747a75fff44ca8890fec2263721180
Autor:
Talal Ashour, Sami Azar, Akram Echtay, Muhammad Farooqi, Tarek Fiad, Mohamed Hassanein, Ahmed Hassoun, Abdul Jabbar, Amin Jayyousi, Kari Ranta, Hani Sabbour, Fatih Tangi, Ibrahim Turfanda
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-11 (2023)
Background: Current guidelines recommend that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with proven cardiovascular benefit should be considered for first-line therapy in patients with type 2 diabetes (T2D) who have/are at high risk of ath
Externí odkaz:
https://doaj.org/article/716fdb93783548ef97d665013e406f57
Autor:
Magdy Abdelhamid, Kamal Al Ghalayini, Khaldoon Al‐Humood, Bülent Altun, Mohammed Arafah, Feras Bader, Mohamed Ibrahim, Hani Sabbour, Ahmed Shawky Elserafy, Hadi Skouri, Mehmet Birhan Yilmaz
Publikováno v:
ESC Heart Failure, Vol 10, Iss 5, Pp 2773-2787 (2023)
Abstract Although epidemiological data on heart failure (HF) with preserved ejection fraction (HFpEF) are scarce in the Middle East, North Africa and Turkey (MENAT) region, Lancet Global Burden of Disease estimated the prevalence of HF in the MENAT r
Externí odkaz:
https://doaj.org/article/98f4327936344d368766ab48407f6785
Autor:
Mohamed Hassanein, Hani Sabbour, Fatheya Al Awadi, Salah Abusnana, Bachar Afandi, Juma Al Kaabi, Alaaeldin Bashier, Francesco Cosentino, Hassan El Tamimi, Mohammed Farghali, M. Hamed Farooqi, Khadija Hafidh, Hussein Heshmat, Rabih Hijazi, Abdul Jabbar, Sami Kenz, Seema Elkhider Nour, Abdullah Shehab, Jeff Shook, Mohamed Suliman, Hosam Zaky, Wael Almahmeed
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-22 (2023)
Background: Cardiovascular diseases (CVDs) are the major cause of mortality and disability in patients with type 2 diabetes mellitus (T2DM). The increased risk of major cardiovascular (CV) events in patients with T2DM causes an estimated 12-year redu
Externí odkaz:
https://doaj.org/article/d5c4827f3e394eedb38da4792e1979cf
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-16 (2022)
Abstract It is well known that diabetes is a prominent risk factor for cardiovascular (CV) events. The level of CV risk depends on the type and duration of diabetes, age and additional co-morbidities. Diabetes is an independent risk factor for atrial
Externí odkaz:
https://doaj.org/article/d149364479274d8fac688cdad67b586d
Autor:
Hani Sabbour MD, Aftab Ahmad MD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
Background: Heart failure (HF) is an important adverse outcome of diabetes mellitus (DM) with high rates of mortality and HF-related hospitalizations. The risk of HF is 2 times higher in patients with DM compared to those without DM. Due to under-rec
Externí odkaz:
https://doaj.org/article/7ae221914b914e87a9c311f1aec5ff07
Autor:
Alper Sonmez, Hani Sabbour, Akram Echtay, Abbas Mahdi Rahmah, Amani Matook Alhozali, Fahad Sulman alSabaan, Fares H. Haddad, Hinde Iraqi, Ibrahim Elebrashy, Samir N. Assaad, Zaheer Bayat, Zeynep Osar Siva, Mohamed Hassanein
Publikováno v:
Journal of Diabetes, Vol 14, Iss 5, Pp 315-333 (2022)
Abstract The upsurge of type 2 diabetes mellitus is a major public health concern in the Middle East and North Africa (MENA) and Africa (AFR) region, with cardiorenal complications (CRCs) being the predominant cause of premature morbidity and mortali
Externí odkaz:
https://doaj.org/article/5b13a0b65efb42018d34679902d42f2b
Autor:
Hani Sabbour, Khwaja Yousuf Hasan, Firas Al Badarin, Haluk Alibazoglu, Andrew L. Rivard, Ingy Romany, Stefano Perlini
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Cardiac amyloidosis is frequently misdiagnosed, denying patients the opportunity for timely and appropriate management of the disease. The purpose of this review and case studies is to raise awareness of the diagnostic “red flags” associated with
Externí odkaz:
https://doaj.org/article/c333068b52234ca087ae54748d3bb837